September 10, 2025Diseases of the Esophagus

Treatment Strategy for Cstage Iv Esophageal Cancer and the Significance of Conversion Surgery

View Full Paper

Ask AI

Bookmark

Overall survival improved with pembrolizumab plus chemotherapy for stage IV esophageal cancer.
Of 30 patients studied, the major response was partial response in 9 cases and stable disease in 10.
Observational analysis across 30 patients revealed significant adverse event rates, including 6 cases of grade 3 toxicity.
Conversion surgery was successfully performed in 7 patients, indicating potential benefits in appropriately selected candidates.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis identifies improved survival with pembrolizumab plus chemotherapy in stage IV cancer patients, suggesting relevance for conversion surgery.

Cite This Study

Kosuke Narumiya (2025) studied this question.

synapsesocial.com/papers/68c23cf6b210217d6478b7fe https://doi.org/10.1093/dote/doaf061.250

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis identifies improved survival with pembrolizumab plus chemotherapy in stage IV cancer patients, suggesting relevance for conversion surgery.

Treatment Strategy for Cstage Iv Esophageal Cancer and the Significance of Conversion Surgery

Key Points

Discussion

Implication

Cite This Study

Treatment Strategy for Cstage Iv Esophageal Cancer and the Significance of Conversion Surgery

Key Points

Discussion

Implication

Cite This Study